WallStreetZenWallStreetZen

NASDAQ: TYRA
Tyra Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TYRA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$69.1M
Current Profit Margin
0%

TYRA Return on Equity

Current Company
-30.3%
Current Industry
-63.5%
Current Market
188%
TYRA's Return on Equity (-30.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TYRA announces earnings.

TYRA Return on Assets

Current Company
-28.5%
Current Industry
2.9%
TYRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TYRA Return on Capital Employed

Current Company
-32.84%
Current Industry
19.5%
TYRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TYRA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TYRA$0.00-$68.78M-$69.13MN/AN/A
MDXG$334.51M$50.76M$74.16M-0.41%N/A
CNTA$6.85M-$165.43M-$151.09MN/AN/A
EYPT$46.02M-$69.00M-$70.80M+58.70%N/A
MGNX$58.75M$5.51M-$9.06M-0.46%N/A
View Top Biotech Stocks

TYRA earnings dates

Next earnings date
May 29, 2024

Tyra Biosciences Earnings & Revenue FAQ

What were TYRA's earnings last quarter?

On Invalid Date, Tyra Biosciences (NASDAQ: TYRA) reported Q4 2023 earnings per share (EPS) of -$0.53, up 76.67% year over year. Total Tyra Biosciences earnings for the quarter were -$22.83 million. In the same quarter last year, Tyra Biosciences's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Tyra Biosciences stock.

What was TYRA's earnings growth in the past year?

As of Q2 2024, Tyra Biosciences's earnings has grown year over year. Tyra Biosciences's earnings in the past year totalled -$69.13 million.

What is TYRA's earnings date?

Tyra Biosciences's earnings date is Invalid Date. Add TYRA to your watchlist to be reminded of TYRA's next earnings announcement.

What was TYRA's revenue last quarter?

On Invalid Date, Tyra Biosciences (NASDAQ: TYRA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Tyra Biosciences's revenue was $0.00.

What was TYRA's revenue growth in the past year?

As of Q2 2024, Tyra Biosciences's revenue has grown null year over year. Tyra Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.